Minerva Neurosciences, Inc. (NERV) › Operating IncomeMinerva Neurosciences, Inc. (NERV) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$3.17M2014: -$54.87M2015: -$26.11M2016: -$30.19M2017: -$41.17M2018: -$51.73M2019: -$75.87M2020: $1.85M2021: -$45.37M2022: -$25.23M2023: -$23.12M2024: -$21.85M2025: -$15.10M-$15.10M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$15.10M+30.9%2024-$21.85M+5.5%2023-$23.12M+8.4%2022-$25.23M+44.4%2021-$45.37M-2556.5%2020$1.85M+102.4%2019-$75.87M-46.7%2018-$51.73M-25.6%2017-$41.17M-36.4%2016-$30.19M-15.6%2015-$26.11M+52.4%2014-$54.87M-1628.2%2013-$3.17M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share